News | March 02, 2026
Emcure partners with Roche to boost nephrology and transplant care in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
AINU is set to accelerate its expansion footprint, enhance operational capabilities
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Subscribe To Our Newsletter & Stay Updated
